Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium to Prevent Diltiazem-Induced Hypotension in Atrial Fibrillation
NCT05691959Phase 2Unknown
- Sponsor
- Ascension
- Start
- Jan 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in hypotension comparing Calcium Gluconate with Placebo (2 arms). Primary endpoint: Incidence of Hypotension at 30 months. Status: unknown.
02
Drugs
calcium gluconate
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05691959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05691959.